YOSHIO YAMAOKA to Cytochrome P-450 CYP2C19
This is a "connection" page, showing publications YOSHIO YAMAOKA has written about Cytochrome P-450 CYP2C19.
Connection Strength
1.534
-
CYP2C19 genotype-guided dosing of proton pump inhibitors: progress in clinical trials and real-world use. Expert Rev Clin Pharmacol. 2026 Jan-Feb; 19(2):133-150.
Score: 0.960
-
CYP2C19 Genotype, CagA Genotype and Antibiotic Resistant
Strain of Helicobacter pylori Infection Asian Pac J Cancer Prev. 2019 Apr 29; 20(4):1243-1247.
Score: 0.150
-
Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease. Expert Rev Gastroenterol Hepatol. 2015; 9(12):1535-47.
Score: 0.117
-
Effect of bacterial and host factors on Helicobacter pylori eradication therapy. Expert Opin Ther Targets. 2015; 19(12):1637-50.
Score: 0.116
-
Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective. Molecules. 2015 Apr 08; 20(4):6068-92.
Score: 0.113
-
Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pylori. J Gastroenterol Hepatol. 2009 Nov; 24(11):1725-32.
Score: 0.078